BeOne Medicines Ltd
203 hedge funds and large institutions have $6.09B invested in BeOne Medicines Ltd in 2019 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 91 increasing their positions, 49 reducing their positions, and 26 closing their positions.
86% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 49
19% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 26
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
2% more funds holding
Funds holding: 199 → 203 (+4)
0.02% more ownership
Funds ownership: 6.33% → 6.35% (+0.02%)
10% less capital invested
Capital invested by funds: $6.8B → $6.09B (-$708M)
17% less call options, than puts
Call options by funds: $9.72M | Put options by funds: $11.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$79.5M |
| 2 |
MAM
Myriad Asset Management
North Point,
Hong Kong
|
+$72.4M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$65.8M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$21.6M |
| 5 |
NSRI
New Silk Road Investment
Singapore
|
+$15.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$71.8M |
| 2 |
O
OrbiMed
New York
|
-$37.3M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$26.7M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$23.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$22.8M |
ONC Hedge Fund Activity: Q2 2019 in Review
203 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q2 2019, worth a combined $6.09B — down 10% from $6.8B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new ONC positions and 26 closed out — a net gain of 5 holders — while 91 added to existing stakes and 49 trimmed.
The largest buyer was Capital International Investors, adding an estimated $79.5M. The largest seller was Canada Pension Plan Investment Board, cutting an estimated $71.8M.
- 203 institutional investors held BeOne Medicines Ltd (ONC) as of Q2 2019, up from 199 in Q1 2019.
- Funds reported $6.09B of BeOne Medicines Ltd stock for Q2 2019, down 10% quarter-over-quarter.
- 31 funds opened new BeOne Medicines Ltd positions in Q2 2019 and 26 closed out, a net change of +5 holders.
- The largest BeOne Medicines Ltd buyer in Q2 2019 was Capital International Investors, an estimated $79.5M added.
- The largest BeOne Medicines Ltd seller in Q2 2019 was Canada Pension Plan Investment Board, an estimated $71.8M sold.
Based on aggregated 13F filings for Q2 2019.